Endocrine Abstracts

Refractory thyroid cancer is rare (4–5 cases/million population/year) and is responsible for most thyroid cancer related death. It includes patients with at least one tumor focus that does not concentrate radioiodine (RAI) or who progress within one year after RAI treatment despite uptake in all lesions.Treatment consists in levothyroxine to maintain a low TSH level and focal treatment modalities (surgery, EBRT, thermo-ablation). In case of multiple...